← Back to companies
Kano Therapeutics
0 open
Cambridge, Massachusetts, United StatesFounded 202114+ employeesSeed raisedSeedPrivate
Last round: seed · Nov 2025(3 rounds total)
Founded by Floris Engelhardt, John Vroom, Mark Bathe, Mark Bathe
Backed by(6 investors)
Vsquared VenturesEngine VenturesZAKA VCMetaplanetTaihill VentureAmino Collective
Kano Therapeutics is a biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials: circular single-stranded DNA. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them.
Open Positions at Kano Therapeutics (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Kano Therapeutics?
